While genetic testing is on the rise – and showing promise for patient selection – innovative treatment options are lagging. But some breakthroughs could soon emerge Inherited retinal diseases (IRDs) are a...
A long-term study on the use of first-generation trabecular micro-bypass stents (iStent) alongside cataract surgery in patients with primary open-angle glaucoma (POAG) demonstrates promising results over a decade, according to a study presented...
Complement inhibitors are emerging as a potential treatment option for geographic atrophy (GA). Paired with artificial intelligence (AI), these medicines will play an increasing role in managing individuals with GA. We asked a...
In a recent discussion hosted by Ophthalmology 360, Dr Eric Donnenfeld and Dr Preeya Gupta delved into the complexities of Demodex blepharitis, shedding light on its prevalence, diagnosis, and groundbreaking treatments. Their insights...